Results 281 to 290 of about 1,176,394 (331)

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Coalition of explainable artificial intelligence and quantum computing in precision medicine. [PDF]

Comput Struct Biotechnol J
Ray S, Bhattacharya P, Mattar EA, Mukhopadhyay A.   +3 more
europepmc   +1 more source

Editorial: Case reports in tumor genomics and ctDNA in precision medicine. [PDF]

Front Med (Lausanne)
Chen L, Chen A.
europepmc   +1 more source

The future of multimorbidity management in the older adults: transforming AI-enabled precision medicine. [PDF]

Front Public Health
Deng W, Zhang LY, Yue JR, Huang XL.
europepmc   +1 more source

Precision medicine with car cells in acute myeloid leukemia: where are we? [PDF]

Front Immunol
Zanetti LC, Tomaz V, de Souza IF, Campregher PV, Hamerschlak N, Kerbauy LN.   +5 more
europepmc   +1 more source

Therapeutic target database 2026: facilitating targeted therapies and precision medicine. [PDF]

Nucleic Acids Res
Zhang Y, Zhou Y, Xu H, Jiang W, Li B, Lai D, Wan C, Wang S, Zhao M, Tan Y, Lu S, Fan T, Liu X, Zhu F, Chen Y.   +14 more
europepmc   +1 more source

Impact of <i>RNF213</i> Variant Status on Revascularization Surgery for Moyamoya Disease: Implications for Precision Medicine

Miki Fujimura, Masaki Ito, Haruto Uchino
openalex   +2 more sources